-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pfizer announced today that the U.
TBE is a viral infection that occurs in the brain and spine and is transmitted to humans through the bite of an infected tick.
Pfizer’s TBE vaccine is marketed in Europe under the trade names TicoVac and FSME-immune.
This BLA is based on more than 40 years of experimental evidence outside the United States.
"Over the years, our TBE vaccine has helped protect millions of people from this potentially serious disease.
Note: This article is intended to introduce medical and health research, not to recommend treatment options.
Reference materials:
[1] US FDA Accepts for Priority Review Pfizer's Application for TicoVac™ (Tick-borne Encephalitis Vaccine).